ArticleAnnals of hematology2024

Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim.

Francesco Marchesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.